Article
Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer
3 Sept 2009
Abstract excerpt
BACKGROUND: Programmed cell death 4 (Pdcd4) is a novel tumour suppressor and originally identified as a neoplastic transformation inhibitor. The aim of this study was to investigate the expression, prognostic significance and potential function of Pdcd4 in ovarian cancer. RESULTS: The expression of Pdcd4 was examined in 30 normal ovarian tissues, 16 borderline and 93 malignant ovarian tissues. A continuous down...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
